1.
Maheshwary N, Chaudhry AA, Nawaz AA, Kafi A, Irfan M, Jalal A, et al. EFFICACY AND COST EFFECTIVENESS OF BIOSIMILAR PEGYLATED INTERFERON α2a 180 µg/RIBAVIRIN IN NON-CIRRHOTIC TREATMENT NAÏVE GENOTYPE 3 PATIENTS. Pak J Phsyiol [Internet]. 2016 Mar. 31 [cited 2024 May 3];12(1):26-8. Available from: https://pjp.pps.org.pk/index.php/PJP/article/view/420